本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

再鼎医药

28.29
-0.5500-1.91%
盘后28.290.00000.00%16:10 EDT
成交量:94.76万
成交额:2,678.66万
市值:31.62亿
市盈率:-13.92
高:28.83
开:28.40
低:27.81
收:28.84
52周最高:44.34
52周最低:23.82
股本:1.12亿
流通股本:1.10亿
量比:1.23
换手率:0.86%
股息:- -
股息率:- -
每股收益(TTM):-2.0329
每股收益(LYR):-2.5984
净资产收益率:-28.41%
总资产收益率:-14.35%
市净率:3.99
市盈率(LYR):-10.89

数据加载中...

2025/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/01/03

重要事件披露

Form 8-K - Current report
2024/12/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

重要事件披露

Form 8-K - Current report
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/08

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities